SFX by Ex Libris Inc.

Title:	PML targeting eradicates quiescent leukaemia-initiating cells
Source:	Nature [0028-0836] Ito, K yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Alizadeh, A A A. "Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling." Nature 403.6769 (2000): 503-11.
description	2.	Shankar, Ganesh M A. "Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory." Nature medicine 14.8 (2008): 837-42.
description	3.	Coussens, Tony M. "Genetic and cellular mechanisms of oncogenesis." Current opinion in genetics & development 18.1 (2008): 1-3.
description	4.	Leitch, Carmen C C. "Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome." Nature genetics 40.4 (2008): 443-8.
description	5.	Al-Hajj, M. "Cancer stem cells and oncology therapeutics." Current opinion in oncology 19.1 (2006): 61-4.
description	6.	Shipp, M. "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning." Nature medicine 8.1 (2002): 68-74.
description	7.	van 't Veer, Laura J J. "Gene expression profiling predicts clinical outcome of breast cancer." Nature 415.6871 (2001): 530-6.
description	8.	Perou, T. "Molecular portraits of human breast tumours." Nature 406.6797 (2000): 747-52.
description	9.	Rosenwald, A. "Gene expression profiling of diffuse large B-cell lymphoma." Leukemia & lymphoma 48.4 (2003): 669-7.
description	10.	Bertina, R M M. "Mutation in blood coagulation factor V associated with resistance to activated protein C." Nature 369.6475 (1994): 64-67.
description	11.	Haass, C. "Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid Î²-peptide." Nature reviews. Molecular cell biology 8.2 (2007): 101-12.
description	12.	Shankar, Ganesh M M. "Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor- dependent signaling pathway." The journal of neuroscience 27.11 (2007): 2866-75.
description	13.	Strittmatter, Stephen M M. "Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers." Nature 457.7233 (2009): 1128-32.
description	14.	Beyreuther, K. "Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides." Nature medicine 3.9 (1997): 1016-1020.
description	15.	Walsh, D.M. M. "Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo." Nature 416.6880 (2002): 535-539.
description	16.	Chang, F. "Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention." Leukemia 17.7 (2003): 1263-1293.
description	17.	Maddocks, Karen D. "Metabolic regulation by p53." Journal of molecular medicine 89.3 (2011): 237-245.
description	18.	Malumbres, M. "Cyclin-dependent kinases: a family portrait." Nature Cell Biology 11.11 (2009): 1275-6.
description	19.	Tabunoki, J. "Molecular network analysis suggests aberrant CREB-mediated gene regulation in the Alzheimer disease hippocampus." Disease Markers 27.5 (2009): 239-252.
description	20.	yilmaz. Nature 441 (2006): 475-.